...
首页> 外文期刊>The Journal of hospital infection >Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature.
【24h】

Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature.

机译:分离多重耐药性鲍曼不动杆菌和铜绿假单胞菌的危险因素:文献系统综述。

获取原文
获取原文并翻译 | 示例
           

摘要

An understanding of the epidemiology of multi-drug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections is necessary in order to develop strategies to curtail their spread. For this purpose, the evidence linking the isolation of MDR A. baumannii and P. aeruginosa with specific risk factors was evaluated. PubMed was searched for the 20-year period from September 1985 to September 2005, and eligible studies were considered to be those that: (1) linked the isolation of A. baumannii and P. aeruginosa with specific risk factors; (2) described the characteristics of the affected patients in detail; and (3) provided data on the antibiotic resistance profile of the isolated micro-organisms. Fifty-five studies were found referring to A. baumannii (28 with case-control methodology and 27 outbreak investigations without case-control methodology), and 42 studies were found referring to P. aeruginosa (25 with case-control methodology and 17 outbreak investigations without case-control methodology). Although heterogeneous study designs and investigated risk factors limited this analysis, it was concluded that acquisition and spread of these micro-organisms appear to be related to a large number of variables. Among the most important were deficiencies in the implementation of infection control guidelines and the use of broad-spectrum antibiotics. Use of carbapenems and third-generation cephalosporins appear to be related to the development of an MDR phenotype by A. baumannii, while carbapenems and fluoroquinolones are implicated in MDR P. aeruginosa. The diversity of risk factors associated with the development of MDR A. baumannii and P. aeruginosa suggests that a separate outbreak investigation should be performed in each hospital setting. The development of innovative control strategies is needed in order to limit the spread of these pathogens.
机译:必须了解多重耐药性鲍曼不动杆菌和铜绿假单胞菌感染的流行病学,以便制定减少其传播的策略。为此,评估了将MDR鲍曼不动杆菌和铜绿假单胞菌的分离与特定危险因素联系起来的证据。从1985年9月到2005年9月的20年期间对PubMed进行了搜索,符合条件的研究被认为是:(1)鲍曼不动杆菌和铜绿假单胞菌的分离与特定的危险因素相关; (2)详细描述受影响患者的特征; (3)提供了有关分离出的微生物的抗生素耐药性数据。发现涉及鲍曼不动杆菌的研究有五十五项(采用病例对照方法进行28例,不采用病例对照方法进行27例暴发调查),涉及铜绿假单胞菌有42例研究(使用病例对照方法中的25例以及暴发调查17例)。没有案例控制方法)。尽管异构研究设计和调查的危险因素限制了此分析,但得出的结论是,这些微生物的获取和传播似乎与大量变量相关。其中最重要的是在执行感染控制指南和使用广谱抗生素方面的缺陷。碳青霉烯和第三代头孢菌素的使用似乎与鲍曼不动杆菌的MDR表型发展有关,而碳青霉烯和氟喹诺酮类药物与铜绿假单胞菌有关。与耐多药鲍曼不动杆菌和铜绿假单胞菌发展相关的危险因素的多样性表明,应在每个医院环境中进行单独的暴发调查。为了限制这些病原体的传播,需要开发创新的控制策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号